Zhejiang Huode (Hopstem) Bioengineering Ltd Co is founded by neuroscience and stem cell scientists from Johns Hopkins University on January 2017 in Hangzhou. Hopstem has world leading advantages in human iPSCs/ESCs neural differentiation, gene editing, cell banking and cell engineering. Hopstem aims to use the most cutting edge technologies to promote the diagnoses, research and therapies of neurological and other disorders. We can provide different types of high quality human neuronal cells, human 2D and 3D models of neural system diseases, neural stem cell culture, differentiation and maturation reagents, cell line establishing services. We are also open to collaborations on biomarker and drug discovery, including drug screening and neurotoxicity tests, as well as clinical trials of neural progenitor cells transplantation in ischemic stroke and brain injury. Hopstem values innovation and quality as the most fundamental bases of a biotechnology company.